What is she best known for?
The fields of study she is best known for:
- Organic chemistry
- Catalysis
- Enzyme
The scientist’s investigation covers issues in Organic chemistry, Enantioselective synthesis, Catalysis, Organocatalysis and Bifunctional.
Her work in Michael reaction, Transition state and Chirality are all subfields of Organic chemistry research.
Her study in Michael reaction is interdisciplinary in nature, drawing from both Moiety and Nitro.
Her Enantioselective synthesis study combines topics in areas such as Reagent, Computational chemistry, Brønsted–Lowry acid–base theory and Non heme iron.
Her research in Catalysis intersects with topics in Primary, Aziridine and Amine gas treating.
Her Organocatalysis research includes elements of Mannich reaction and Autocatalysis.
Her most cited work include:
- Recent Advances in Asymmetric Organocatalytic 1,4‐Conjugate Additions (934 citations)
- Chiral BINOL-derived phosphoric acids: privileged Brønsted acid organocatalysts for C–C bond formation reactions (268 citations)
- Highly enantioselective addition of ketones to nitroolefins catalyzed by new thiourea–amine bifunctional organocatalysts (256 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Organic chemistry, Enantioselective synthesis, Catalysis, Organocatalysis and Combinatorial chemistry.
Organic chemistry is a component of her Michael reaction, Bifunctional, Nitro, Addition reaction and Moiety studies.
Her Enantioselective synthesis study combines topics from a wide range of disciplines, such as Brønsted–Lowry acid–base theory, Stereochemistry, Primary and Amine gas treating.
Svetlana B. Tsogoeva combines subjects such as Yield and Tripeptide with her study of Catalysis.
Her Organocatalysis research incorporates themes from In situ, Polymer chemistry, Domino, Computational chemistry and Cascade reaction.
Her research investigates the link between Combinatorial chemistry and topics such as Reagent that cross with problems in Atom economy.
She most often published in these fields:
- Organic chemistry (35.50%)
- Enantioselective synthesis (31.36%)
- Catalysis (31.36%)
What were the highlights of her more recent work (between 2018-2021)?
- Combinatorial chemistry (20.71%)
- In vitro (7.10%)
- Artemisinin (10.06%)
In recent papers she was focusing on the following fields of study:
Combinatorial chemistry, In vitro, Artemisinin, Quinoline and Click chemistry are her primary areas of study.
Her Combinatorial chemistry research integrates issues from Metal free, Cascade reaction, Catalysis, Visible spectrum and Aryl.
In the field of Catalysis, her study on Enantioselective synthesis, Non heme iron and Organocatalysis overlaps with subjects such as Environmentally friendly.
Svetlana B. Tsogoeva merges Enantioselective synthesis with Photoredox catalysis in her research.
Her In vitro research is multidisciplinary, incorporating perspectives in Mitochondrion, Human cytomegalovirus and Cancer research.
Her Human cytomegalovirus research includes themes of Drug development, Pharmacology and Drug.
Between 2018 and 2021, her most popular works were:
- Artemisinin–(Iso)quinoline Hybrids by C−H Activation and Click Chemistry: Combating Multidrug‐Resistant Malaria (35 citations)
- Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells. (15 citations)
- Synthesis of new betulinic acid/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities. (14 citations)
In her most recent research, the most cited papers focused on:
- Organic chemistry
- Catalysis
- Enzyme
Svetlana B. Tsogoeva spends much of her time researching Human cytomegalovirus, In vitro, Pharmacology, Artemisinin and Drug.
Her research integrates issues of Drug development and Biochemistry in her study of Human cytomegalovirus.
Svetlana B. Tsogoeva has included themes like Dimer, Betulin and Growth inhibition in her Drug development study.
Her work carried out in the field of In vitro brings together such families of science as Tamoxifen and Cancer research.
Her Pharmacology research focuses on Viral replication and how it connects with Potency, Antiviral drug and Experimental drug.
Her Drug research incorporates elements of Computational biology, Drug discovery and Ganciclovir.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
